Dr. William Farrar Named CEO, James Cancer Hospital and Solove Research Institute

August 29, 2019
Dr. Willliam Farrar

COLUMBUS, Ohio – After serving as the interim leader for almost two years, Dr. William Farrar will become CEO of The Ohio State University Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (The James), pending approval by The Ohio State University Board of Trustees.

In this role, he will report to Dr. Hal Paz, executive vice president and chancellor for health affairs at Ohio State and CEO of The Ohio State University Wexner Medical Center.

Farrar is a surgical oncologist and has a long, successful history with Ohio State, serving on The James medical staff since it opened in July 1990. The late Dr. Arthur G. James, for whom the hospital is named, mentored and later worked alongside Farrar.

“Dr. Farrar’s experience with this fine institution makes him ideally suited to lead The James toward even greater heights. I look forward to working together to advance research-based cancer care,” Paz said.

In addition to being clinically active, Farrar has had many Ohio State leadership positions. Currently, he holds the Dr. Arthur G. and Mildred C. James – Richard J. Solove Chair in Surgical Oncology, is director of the Stefanie Spielman Comprehensive Breast Center and is a member of the Molecular Carcinogenesis and Chemoprevention Research Program in The Ohio State University Comprehensive Cancer Center. He also directed the Division of Surgical Oncology for 28 years and was director of medical affairs at The James for 22 years.

“We’ve built a tremendous cancer hospital and research enterprise in Columbus, and I am honored to continue to do my part to help lead our clinical enterprise as we embrace a very hopeful new area of genomic-driven care and immuno-oncology approaches that allow us to offer personalized, more effective treatment options to our patients,” Farrar said.

On a national level, Farrar serves as president of the U.S. National Committee for International Union Against Cancer. He’s also principal investigator for the National Surgical Adjuvant Breast and Bowel Project Clinical Trial group at Ohio State. He has served on numerous national committees including the Training Directions Committee for the Society of Surgical Oncology, the Joint Council for Approval of Advanced Training in Head and Neck Oncology Surgery, the American College of Surgeons Committee on Cancer and the American Association of Clinical Endocrinologists.

Farrar has published more than 100 cancer research journal articles along with several book chapters and scientific abstracts. He served for many years on the editorial boards for the Journal of Surgical Oncology, the Annals of Surgical Oncology and the Southwest Oncology Group.

His national honors include 18 appearances on the Castle Connolly list of "America’s Top Doctors" and 16 appearances on the “Best Doctors in America” list, as well as being rated in the top 10% of physicians in the nation for patient satisfaction in 2017.

###

Media Contacts:

Amanda J. Harper
OSUCCC – James Media Relations
614-685-5420
Amanda.Harper2@osumc.edu

Marti Leitch
Wexner Medical Center Media Relations
614-293-3737
Marti.Leitch@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).